drugset / Trial / NCT00709046
High Dose Versus Standard Dose Proton Pump Inhibitor (PPI) in High-risk Bleeding Peptic Ulcers After Combined Endoscopic Treatment
RandomizedParallel-groupSingle-blindTreatment
Summary
The study was designed to evaluate the efficacy an adjuvant use of standard dose or high dose of proton pump inhibitor after combined endoscopic hemostasis therapy.
Timeline
- Start
- 2008-01
- Primary completion
- 2010-01
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pantoprazole | Other / unclassified | 8 mg | Intravenous |
| Subject | Pantoprazole | Other / unclassified | 40 mg | Intravenous |